RYOIX - Rydex Biotechnology Inv

Nasdaq - Nasdaq Delayed Price. Currency in USD
91.67
+1.73 (+1.92%)
At close: 8:00PM EST
Stock chart is not supported by your current browser
Previous Close89.94
YTD Return28.42%
Expense Ratio (net)1.37%
CategoryHealth
Morningstar Rating★★★
Morningstar Risk Rating★★★★★
Last Cap Gain0.00
Net Assets329.03M
Beta (3y)1.35
Yield0.00%
Holdings Turnover207.00%
Last Dividend0.00
Inception DateApr 1, 1998
Average for CategoryN/A
  • We're sorry we weren't able to find anything about this topic.